Immunoglobulin A nephropathy: epidemiology and clinical phenotypes in the Republic of Belarus
https://doi.org/10.58708/2074-2088.2026-1(37)-85-91
Abstract
The aim of the study was to assess the primary incidence of immunoglobulin A nephropathy (IgAN) based on population data, analyzing the frequency of its various phenotypic variants. For the first time in the Republic of Belarus, a study was conducted using a kidney biopsy registry from Minsk for the period from 2010 to 2020. An increase in the incidence of IgAN was observed, rising from 1,6 per 100 000 in 2010 to 2,0 per 100 000 of the adult population in 2020. The more frequent clinical phenotype was asymptomatic, occurring in 67,4% of cases, while the adverse clinical course manifested as acute kidney injury or chronic kidney disease, which over a 10-year observation period led to the initiation of kidney replacement therapy in 33,3% and 50,0% of cases, respectively.
About the Authors
K. S. Komissarov
ГУ «Минский НПЦ хирургии, трансплантологии и гематологии»;
УО «Белорусский государственный медицинский университет»
Belarus
Belarus
O. V. Krasko
ГНУ «Объединённый институт проблем информатики НАН Беларуси
Belarus
Belarus
V. S. Pilotovich
УО «Белорусский государственный медицинский университет»
Belarus
Belarus
References
1. Ghaddar, M. IgA Nephropathy: Epidemiology and Disease Risk Across the World / M. Ghaddar, M. Canney, S.J. Barbour // Seminars in Nephrology. – 2024. – Vol. 44, №5. – P. 151564. https://doi.org/10.1016/j.semnephrol.2025.151564.
2. Комиссаров, К.С. Гистопатологический спектр болезней почек по данным нефробиопсий, выполненных в Минске, Республика Беларусь / К.С. Комиссаров, М.В. Дмитриева, Т.А. Летковская // Клиническая нефрология. – 2020. – № 2. – С. 26-30. https://dx.doi.org/10.18565/nephrology.2020.2.26-00
3. A new equation to estimate glomerular filtration rate / A.S. Levey, L.A. Stevens, C.H. Schmid [et al.] // Annals of Internal Medicine. – 2009. – Vol. 150, №9. – P. 604-612. https://doi.org/10.7326/0003-4819-150-9-200905050-00006
4. R: The R Project for Statistical Computing [Electronic resource]. – Mode of access: https://www.R-project.org/. – Date of access: 24.02.2026.
5. The incidence and prevalence of IgA nephropathy in Europe / C.J. Willey, R. Coppo, F. Schaefer [et al.] // Nephrology Dialysis Transplantation. – 2023. – Vol. 38, №10. – P. 2340-2349. https://doi.org/10.1093/ndt/gfad082
6. Rivera, F. Clinicopathologic correlations of renal pathology in Spain / F. Rivera, J. Lopez-Gomez, R. Perez-Garcia // Kidney International. – 2004. – Vol. 66, №3. – P. 898-904. https://doi.org/10.1111/j.1523-1755.2004.00833.x
7. Predicting the risk for dialysis or death in IgA nephropathy / F. Berthoux, H. Mohey, B. Laurent [et al.] // Journal of the American Society of Nephrology. – 2011. – Vol. 22, №4. – P. 752-761. https://doi.org/10.1681/asn.2010040355.
8. Long-Term Outcomes in IgA Nephropathy / D. Pitcher, F. Braddon, B. Hendry [et al.] // Clinical Journal of the American Society of Nephrology. – 2023. – Vol. 18, №6. – P. 727-738. https://doi.org/10.2215/cjn.0000000000000135
9. Иммуноглобулина А-нефропатия в белорусской когорте. Клинико-морфологические особенности, факторы, ассоциированные с неблагоприятным исходом / К.С. Комиссаров, О.В. Краско, М.В. Дмитриева [и др.] // Клиническая нефрология. – 2022. – Т. 14, №3. – С. 25-33. https://dx.doi.org/10.18565/nephrology.2022.3.25-33
10. IgA nephropathy / E. Stamellou, C. Seikrit, S.C.W. Tang [et al.] // Nature Reviews Disease Primers. – 2023. – Vol. 9, №1. – P. 67. https://doi.org/10.1038/s41572-023-00476-9
11. Корабельников, Д.И. IgA-нефропатия: прогнозирование рисков прогрессирования / Д.И. Корабельников, М.Е. Манцаева // Фармакоэкономика. Современная фармакоэкономика и фармакоэпидемиология. – 2025. – Т. 18, №2. – С. 294-303. https://doi.org/10.17749/2070-4909/farmakoekonomika.2025.298
12. The association of microhematuria with mesangial hypercellularity, endocapillary hypercellularity, crescent score and renal outcomes in immunoglobulin A nephropathy / S.A. Bobart, M.P. Alexander, K. Shawwa [et al.] // Nephrology Dialysis Transplantation. – 2021. – Vol. 36, №5. – P. 840-847. https://doi.org/10.1093/ndt/gfz267
13. Quantifying Duration of Proteinuria Remission and Association with Clinical Outcome in IgA Nephropathy / M. Canney, S.J. Barbour, Y. Zheng [et al.] // Journal of the American Society of Nephrology. – 2021. – Vol. 32, №2. – P. 436-447. https://doi.org/10.1681/asn.2020030349
14. Machine learning-based unsupervised phenotypic clustering analysis of patients with IgA nephropathy: Distinct therapeutic responses of different groups / Y. Wang, Q. Wen, X. Lian [et al.] // Chinese Medical Journal. – 2026. – Vol. 139, №1. – P. 83-92. https://doi.org/10.1097/cm9.0000000000003422
Review
For citations:
Komissarov K.S., Krasko O.V., Pilotovich V.S. Immunoglobulin A nephropathy: epidemiology and clinical phenotypes in the Republic of Belarus. Medical and Biological Problems of Life Activity. 2026;(1):85-91. (In Russ.) https://doi.org/10.58708/2074-2088.2026-1(37)-85-91
Views:
25
JATS XML
Email this article 